维普中文期刊产品整合服务
79篇 您的检索式:作者名="Veldt"
    题名 作者 年代 出处 被引量
1Positron emission tomography to assess hypoxia and perfusion in lung cancer显示文摘In lung cancer, tumor hypoxia is a characteristic feature, which is associated with a poor prognosis and resistance to both radiation therapy and chemotherapy. As the development of tumor hypoxia is associated with decreased perfusion, perfusion measurements provide more insight into the relation between hypoxia and perfusion in malignant tumors. Positron emission tomography(PET) is a highly sensitive nuclear imaging technique that is suited for non-invasive in vivo monitoring of dynamic processes including hypoxia and its associated parameter perfusion. The PET technique enables quantitative assessment of hypoxia and perfusion in tumors. To this end, consecutive PET scans can be performed in one scan session. Using different hypoxia tracers, PET imaging may provide insight into the prognostic significance of hypoxia and perfusion in lung cancer. In addition, PET studies may play an important role in various stages of personalized medicine, as these may help to select patients for specifictreatments including radiation therapy, hypoxia modifying therapies, and antiangiogenic strategies. In addition, specific PET tracers can be applied for monitoring therapy. The present review provides an overview of the clinical applications of PET to measure hypoxia and perfusion in lung cancer. Available PET tracers and their characteristics as well as the applications of combined hypoxia and perfusion PET imaging are discussed.Eline E Verwer Ronald Boellaard Astrid AM van der Veldt 2014World Journal of Clinical Oncology2014,5,5:3
2Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing显示文摘Bartholomeus Johannes Veldt Fabrice Lainé Anne Guillygomarc’h Laurence Lauvin Karim Boudjema Michel Messner Pierre Brissot Yves Deugnier Romain Moirand 2002Journal of Hepatology2002,,1:2
3Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis显示文摘Raoel Maan Adriaan J. van der Meer Bettina E. Hansen Jordan J. Feld Heiner Wedemeyer Jean-Fran?ois Dufour Hooman F. Zangneh Frank Lammert Michael P. Manns Stefan Zeuzem Harry L.A. Janssen Robert J. de Knegt Bart J. Veldt 2014Journal of Hepatology2014,,:2
4The Course of Posttransplant Hepatitis C Infection: Comparative Impact of Donor and Recipient Source of the Favorable IL28B Genotype and Other Variables显示文摘Andres Duarte-Rojo Bart J. Veldt David D. Goldstein Hans L. Tillman Kymberly D. Watt Julie K. Heimbach John G. McHutchison John J. Poterucha Florencia Vargas-Vorackova Michael R. Charlton 2012Transplantation Journal2012,,2:2
5Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrho- sis and diabetes mellitus显示文摘VELDT B J CHEN W HEATHCOTE E J 2008Hepatology2008,47,6:1
6Rapid decrease in delivery of chemotherapy to tumors after anti- VEGF therapy: implications for scheduling of anti- angiogenic drugs 显示文摘Van der Veldt AA Lubberink M Bahce I 2012Cancer Cell2012,21,1:1
7Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity 显示文摘van Erp NP Eechoute K van der Veldt AA 2009J Clin Oncol2009,27,26:1
8Interleukin- 28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in pa- tients with hepatitis C virus infection显示文摘Charlton M R Thompson A Veldt B J 2011Hepatology2011,53,1:1
9Vera- pamil induced erythermalgia 显示文摘Nanayakkara PW van der Veldt AA Simsek S etal 2007Neth J Med2007,65,9:1
10Associationbetween sustained virological response and all - cause mor-tality among patients with chronic hepatitis C and advancedhepatic fibrosis sustained virological response and all - causemortality显示文摘van der MEER AJ VELDT BJ FELD JJ 2012JAMA2012,308,24:1
11Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis显示文摘Veldt BJ Heathcote JE Wedemeyer H 0,,:1
12Hepatitis C 2002 guidelines: summary and annotations显示文摘Orient H Vrolijk JM Veldt B J 2003Scand J Gastroenterol Suppl2003,,239:1
13Sus- tained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis 显示文摘VELDT B J HEATHCOTE E J WEDEMEYER H 2007Ann In- tern Med2007,147,10:1
14Sustained virologicresponse and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis显示文摘Veldt BJ Heathcote EJ Wedemeyer H 2007Ann Int Med2007,147,10:1
15Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs显示文摘Astrid A.M. Van der Veldt Mark Lubberink Idris Bahce Maudy Walraven Michiel P. de Boer Henri N.J.M. Greuter N. Harry Hendrikse Jonas Eriksson Albert D. Windhorst Pieter E. Postmus Henk M. Verheul Erik H. Serné Adriaan A. Lammertsma Egbert F. Smit 2012Cancer Cell2012,,:1
16Determination of theregression rate of a fast moving solid/liquid interface using ultrasonics显示文摘Chiffoleau GJ Steinberg TA Veldt M 2001Ultrasonics2001,39,3:1
17Interleukin- 28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review显示文摘Duarte-Rojo A Budhraja V Veldt BJ 2013Liver Transpl2013,19,12:1
18Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis显示文摘van der Meer AJ Veldt BJ Feld JJ 0,,24:1
19Pharmacoge-netic pathway analysis for determination of sunitinib-induced tox-icity显示文摘van Erp NP Eechoute K van der Veldt AA 2009J Clin Oncol2009,27,26:1
20Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability:initial experience with downsizing to reconsider cytoreductive surgery显示文摘Bex A van der Veldt AA Blank C 2009World Journal of Urology2009,,04:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费